Wellgistics Health pays $2.5M for exclusive license of DataVault AI patents for PharmacyChain

Wellgistics Health, Inc.

License fee of $2.5M to DataVault AI, payable by Dec 31, 2025; plus 13% royalty on net profit from PharmacyChain.
Minimum annual royalty of $1M from 2028 onward, contingent on PharmacyChain achieving $2M annual net profit.
Partnership aims to disrupt $634B US prescription drug industry using blockchain smart contracts and AI hub EinsteinRx.
Wellgistics connects 6,500+ pharmacies and 200+ manufacturers; expects to reduce PBM rebates and improve transparency.

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

Wellgistics Health, Inc. entered into License Agreement with DataVault AI Inc. valued at $2,500,000.00 (effective 2025-11-24).

Action: entry
Agreement: license
Counterparty: DataVault AI Inc.
Value: $2,500,000.00
Effective: 2025-11-24

Exact text from the filing

On November 24, 2025, Wellgistics Health, Inc. (the “ Company ”), entered into a license agreement (the “ License Agreement ”) with DataVault AI Inc. (“ DataVault ”)

View on SEC.gov

84 material agreements filed in the last 30 days. Browse all material agreements →

Wellgistics Health, Inc. filing history →

Source: SEC EDGAR

accession 0001493152-25-024999

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.